In the last decade, biopharmaceutical industries have mobilized quickly in response to pandemics. Developing vaccines and manufacturing large doses in response to an emergency is often constrained by existing platforms and facility configurations. Learn how vaccine manufacturing can evolve to tackle future global health challenges.
A recent Virtual Think Tank focused on the challenges and trends influencing design considerations for viral vector manufacturing facilities, and how they can impact companies developing cell and gene therapies.
Prior to making critical capacity decisions, a small biotech company completed an economic evaluation of manufacturing options to ensure it was selecting the best strategy for its manufacturing. Discover the critical elements of this analysis that may help to balance your assessment.
What is big data? What is Bioprocess 4.0? How do you leverage data to make better informed decisions? This video explores the role data plays in biopharma scale-up and manufacturing. Learn how to make data work for you.